128 related articles for article (PubMed ID: 11073742)
1. Visceral leishmaniasis during childhood in southern Greece.
Maltezou HC; Siafas C; Mavrikou M; Spyridis P; Stavrinadis C; Karpathios T; Kafetzis DA
Clin Infect Dis; 2000 Nov; 31(5):1139-43. PubMed ID: 11073742
[TBL] [Abstract][Full Text] [Related]
2. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
[TBL] [Abstract][Full Text] [Related]
3. Visceral childhood leishmaniasis in southern Turkey: experience of twenty years.
Dursun O; Erişir S; Yeşilipek A
Turk J Pediatr; 2009; 51(1):1-5. PubMed ID: 19378883
[TBL] [Abstract][Full Text] [Related]
4. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
[TBL] [Abstract][Full Text] [Related]
5. [First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France].
Minodier P; Robert S; Noël G; Blanc P; Retornaz K; Garnier JM
Arch Pediatr; 2005 Jul; 12(7):1102-8. PubMed ID: 15964525
[TBL] [Abstract][Full Text] [Related]
6. Drug regimens for visceral leishmaniasis in Mediterranean countries.
Gradoni L; Soteriadou K; Louzir H; Dakkak A; Toz SO; Jaffe C; Dedet JP; Campino L; Cañavate C; Dujardin JC
Trop Med Int Health; 2008 Oct; 13(10):1272-6. PubMed ID: 18764817
[TBL] [Abstract][Full Text] [Related]
7. [Visceral childhood leishmaniasis: diagnosis and treatment].
Prieto Tato LM; La Orden Izquierdo E; Guillén Martín S; Salcedo Lobato E; García Esteban C; García-Bermejo I; Ramos Amador JT
An Pediatr (Barc); 2010 May; 72(5):347-51. PubMed ID: 20378427
[TBL] [Abstract][Full Text] [Related]
8. Effect of meglumine antimoniate on the pancreas during treatment of visceral leishmaniasis in children.
Shahian M; Alborzi A
Med Sci Monit; 2009 Jun; 15(6):CR290-3. PubMed ID: 19478699
[TBL] [Abstract][Full Text] [Related]
9. Pediatric visceral leishmaniasis in southern France.
Minodier P; Piarroux R; Garnier JM; Unal D; Perrimond H; Dumon H
Pediatr Infect Dis J; 1998 Aug; 17(8):701-4. PubMed ID: 9726344
[TBL] [Abstract][Full Text] [Related]
10. Visceral leishmaniasis in 13 pediatric patients in Turkey: treatment experience.
Arik Yilmaz E; Tanir G; Tuygun N; Taylan Ozkan A
Turkiye Parazitol Derg; 2009; 33(4):259-62. PubMed ID: 20101572
[TBL] [Abstract][Full Text] [Related]
11. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
Oliva G; Foglia Manzillo V; Pagano A
Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
[TBL] [Abstract][Full Text] [Related]
12. Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis.
Sundar S; Jha TK; Sindermann H; Junge K; Bachmann P; Berman J
Pediatr Infect Dis J; 2003 May; 22(5):434-8. PubMed ID: 12792385
[TBL] [Abstract][Full Text] [Related]
13. Rapid clearance of circulating Leishmania kinetoplast DNA after treatment of visceral leishmaniasis.
Disch J; Oliveira MC; Orsini M; Rabello A
Acta Trop; 2004; 92(3):279-83. PubMed ID: 15533299
[TBL] [Abstract][Full Text] [Related]
14. Short report: Treatment failure due to mixed infection by different strains of the parasite Leishmania infantum.
Antoniou M; Doulgerakis C; Pratlong F; Dedet JP; Tselentis Y
Am J Trop Med Hyg; 2004 Jul; 71(1):71-2. PubMed ID: 15238692
[TBL] [Abstract][Full Text] [Related]
15. Human and canine leishmaniasis in asymptomatic and symptomatic population in Northwestern Greece.
Papadopoulou C; Kostoula A; Dimitriou D; Panagiou A; Bobojianni C; Antoniades G
J Infect; 2005 Jan; 50(1):53-60. PubMed ID: 15603841
[TBL] [Abstract][Full Text] [Related]
16. [Visceral leishmaniasis in Alicante. Analysis of 21 cases].
Portilla Sogorb J; Rosas Gómez de Salazar JC; Casellas Valde JA; Abad Gosálbez A; Monpel Sanjuan A; Palmero Cabezas MF
Rev Clin Esp; 1990 Jun; 187(2):53-5. PubMed ID: 2244057
[TBL] [Abstract][Full Text] [Related]
17. A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience.
Cascio A; di Martino L; Occorsio P; Giacchino R; Catania S; Gigliotti AR; Aiassa C; Iaria C; Giordano S; Colomba C; Polara VF; Titone L; Gradoni L; Gramiccia M; Antinori S
J Antimicrob Chemother; 2004 Jul; 54(1):217-20. PubMed ID: 15150166
[TBL] [Abstract][Full Text] [Related]
18. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
Lachaud L; Bourgeois N; Plourde M; Leprohon P; Bastien P; Ouellette M
Clin Infect Dis; 2009 Jan; 48(2):e16-22. PubMed ID: 19093811
[TBL] [Abstract][Full Text] [Related]
19. [Infantile visceral leishmaniasis in Morocco. A review of 67 cases managed at the Rabat Hospital for children (1979-1988)].
Mikou N; Balafrej A; Benhamou B; Mikou S; Baroudi A
Ann Pediatr (Paris); 1991 Sep; 38(7):497-502. PubMed ID: 1659303
[TBL] [Abstract][Full Text] [Related]
20. Are there differences in clinical and laboratory parameters between children and adults with American visceral leishmaniasis?
Caldas AJ; Costa J; Aquino D; Silva AA; Barral-Netto M; Barral A
Acta Trop; 2006 Mar; 97(3):252-8. PubMed ID: 16420954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
